Ken Fisher
NBP

Ken Fisher’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Ken Fisher’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-861
Closed -$2.57K – 1217
2023
Q2 		$2.57K Buy
+861
New +$2.77K ﹤0.01% 1132

Other funds holding NBP

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Ken Fisher's NBP Position: Q3 2023 in Review

Ken Fisher sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q3 2023, closing a stake of 861 shares — an estimated $2.57K sold.

Ken Fisher first reported a position in NBP in Q2 2023 and held it in 1 quarter. The position peaked at $2.57K in Q2 2023. 47 funds tracked by Wall St. Rank hold NBP as of Q3 2023.

  • Ken Fisher reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q3 2023 after selling out during the quarter.
  • Ken Fisher sold 861 NovaBridge Biosciences American Depositary Shares shares in Q3 2023, an estimated $2.57K.
  • Ken Fisher first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2023 and held it in 1 quarter.
  • Ken Fisher's NovaBridge Biosciences American Depositary Shares position peaked at $2.57K in Q2 2023.
  • 47 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q3 2023.

Based on Fisher Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.